Skip to content

Clinical trials

Phase 3 Head and Neck Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 3 Country / region: Belgium Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20062
20081
20111
20121
20151
20172
20181
20191
20204
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Active, not recruiting3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
AstraZeneca2
Boehringer Ingelheim2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Adlai Nortye Biopharma Co., Ltd.1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Genmab1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms22
Squamous Cell Carcinoma of Head and Neck10
Laryngeal Diseases3
Carcinoma, Squamous Cell2
Adenocarcinoma1
Bronchial Diseases1
Carcinoma1
Carcinoma, Bronchogenic1
Carcinoma, Non-Small-Cell Lung1
Lung Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.